<bill session="115" type="hr" number="787" updated="2019-04-18T15:55:08Z">
  <state datetime="2018-03-20T14:19:15-04:00">PASSED:SIMPLERES</state>
  <status>
    <unknown datetime="2018-03-20T14:19:15-04:00"/>
  </status>
  <introduced datetime="2018-03-19"/>
  <titles>
    <title type="official" as="introduced">Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.</title>
    <title type="display">Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001248"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-03-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-03-19">
      <text>The House Committee on Rules reported an original measure, H. Rept. 115-613, by Mr. Burgess.</text>
    </action>
    <action datetime="2018-03-19T19:08:52-04:00">
      <text>The resolution provides for one hour of debate on each bill. The resolution makes in order only the further amendment to H.R. 4566 printed in the report. No further amendments on either bill are made in order. Section 3 of the resolution makes it in order to consider any resolution reported from the Rules Committee on the day it is reported through the legislative day of March 23, 2018. Section 4 grants suspension authority on the legislative days of March 22, 2018 and March 23, 2018. Section 5 of the resolution amends section 3(a) of H. Res. 5.</text>
    </action>
    <calendar datetime="2018-03-19" state="REPORTED" calendar="House" number="133">
      <text>Placed on the House Calendar, Calendar No. 133.</text>
    </calendar>
    <action datetime="2018-03-20T12:17:06-04:00">
      <text>Considered as privileged matter.</text>
      <reference ref="CR H1704-1710" label="consideration"/>
    </action>
    <action datetime="2018-03-20T12:20:15-04:00">
      <text>DEBATE - The House proceeded with one hour of debate on H. Res. 787.</text>
    </action>
    <action datetime="2018-03-20T13:04:16-04:00">
      <text>POSTPONED PROCEEDINGS - At the conclusion of debate on H. Res. 787, the Chair put the question on ordering the previous question and by voice vote announced that the ayes had prevailed. Mr. Hastings demanded the yeas and nays, and the Chair postponed further proceedings on the question of ordering the previous question until later in the legislative day.</text>
    </action>
    <action datetime="2018-03-20T13:41:14-04:00">
      <text>Considered as unfinished business.</text>
    </action>
    <action datetime="2018-03-20T14:06:14-04:00">
      <text>On ordering the previous question Agreed to by the Yeas and Nays: 233 - 181 (Roll no. 117).</text>
      <reference ref="CR H1704" label="consideration"/>
      <reference ref="CR H1704" label="text"/>
    </action>
    <vote how="roll" type="vote" roll="118" datetime="2018-03-20T14:19:15-04:00" where="h" result="pass" state="PASSED:SIMPLERES">
      <text>On agreeing to the resolution Agreed to by recorded vote: 225 - 183 (Roll no. 118).</text>
      <reference ref="CR H1704" label="text"/>
    </vote>
    <action datetime="2018-03-20T14:19:17-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSRU" name="House Rules" activity="Origin, Reporting"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="procedurally-related" number="4566"/>
    <bill type="h" session="115" relation="procedurally-related" number="5247"/>
  </relatedbills>
  <subjects>
    <term name="Congress"/>
    <term name="House of Representatives"/>
    <term name="Legislative rules and procedure"/>
  </subjects>
  <amendments/>
  <summary date="2018-03-19T04:00:00Z" status="Introduced in House">Sets forth the rule for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes.</summary>
  <committee-reports>
    <report>H. Rept. 115-613</report>
  </committee-reports>
</bill>
